GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. It operates through the Pollution Removal and Bio businesses. Its products include carbon filter, coating resin, media, air refresher, mask, drugs and others. The company was founded on March 10, 1998 and is headquartered in Daejeon, South Korea.

Research Development Foundation is an American private company that operates as noncommercial research organizations.

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

EVIAGENICS is a biotechnology company generating new products and improved manufacturing processes for the chemical and pharmaceutical industry by applying its unique in vivo recombination technology. After the successful validation of the technology in several collaborations with industrial partners from red and white biotechnology EVIAGENICS will focus its activities on the development of a technology platform for the efficient recombination and expression of metabolic pathways in cells. These reprogrammed cells will be able to transform sugars from cheap renewable sources like feedstock into numerous new high value compounds.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Develops and manufactures agricultural and noncrop products

Bio3 Research SRL is engaged in the research, identification and development of novel therapeutic agents, specializing in the biotechnology, bioelectronics, and biomedicine fields. The firm develops proprietary compounds that serve as inhibitors in diseases related to High Mobility Group Box 1 (HMGB1) protein over-expression and biological properties. It monitors the effect of developed and patented biological agents on cardiovascular disorders, renal disorders, and connective tissue regeneration, such as cartilage repair, wound healing, and bone matrix regeneration. It collaborates with biopharmaceutical companies, academies, and scientists, with focus on intellectual property transfer, patent registration, and commercialization of novel products in the pharmaceutical marketplace. The company was founded by Francesco Paolo Pilato in 2001 and is headquartered in Milan, Italy.

Gene Bridges GmbH specializes in DNA engineering. The firm focuses on market development, product development and innovation of DNA engineering in functional genomics studies and providing customer-specific solutions for DNA engineering projects. Its patented Red/ET Recombination, also known as lambda-red mediated recombination or recombineering, enables cloning and modification of DNA molecules regardless of restriction sites and is useful for the generation of targeting vectors necessary to create transgenic mouse models. The company was founded in 2000 and is headquartered in Heidelberg, Germany.

UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Ferring BV offers pharmaceutical products. It offers medicines in Gynaecology, Gastroenterology, Endocrinology and Urology. The company was founded in 1984 and is headquartered in Hoofddorp, Netherlands.

In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. At Takeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer. They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.

Xenomine Co., Ltd. is a research and development company that seeks to discover functional genes and disease markers based on world-class technology in functional dielectric and proteome analysis and create high added value through its technology transfer and its utilization business. It originated from the lab and was founded by professors in the Department of Life Sciences, Ph.D. and Ph.D. researchers, and researchers from major companies such as Pacific and LG.

The Brazilian Agricultural Research Corporation (Embrapa) was founded on April 26, 1973, and is under the aegis of the Brazilian Ministry of Agriculture, Livestock, and Food Supply. Since our foundation, and with our partners from the National Agricultural Research System, we have taken on the challenge to develop a genuinely Brazilian model of tropical agriculture and livestock to overcome the barriers that limited the production of food, fiber, and fuel in our country. This effort has helped to change Brazil. Nowadays, our agriculture is one of the most efficient and sustainable ones in the planet. We have incorporated a wide area of formerly degraded Cerrado lands into our production systems; a region that now accounts for nearly 50% of our grain production. We have quadrupled the beef and pork supply and increased the chicken supply 22-fold. These are some of the achievements that took the country from the condition of basic food importer to one of the world's largest food producers and exporters.

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

Plant Genetic Systems International, part of Bayer AG, is a Dutch company that provides biological products. The firm was founded by Daniel D. Adams.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Beijing Shadong Biotech Co. Ltd. is a Chinese private company that develops therapeutics for treatment of cervical cancer.